Drug Trial Radar · NCT05037760
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
Last checked: Nov 19, 2026Latest source record: Feb 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
135
Planned (sponsor's estimate)
Start
Dec 16, 2021
Primary completion
Feb 28, 2028
Study completion Feb 28, 2030
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Sep 8, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of this study is to learn how safe elritercept is and how well it is tolerated when taken alone and in combination with the JAK inhibitor, ruxolitinib. Other aims are to learn about the effects of elritercept on the signs and symptoms of MF when taken with or without ruxolitinib and to learn how elritercept affects the body, how the body processes elritercept, and the effects of elritercept on anemia when taken with or without ruxolitinib The study will also check on how safe elritercept is and how well it is tolerated.
Conditions
- Myelofibrosis
Interventions
ElriterceptDrug
Elritercept SC injection.
RuxolitinibDrug
Ruxolitinib tablet.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Number of Participants with Adverse Events (AEs), Dose Limiting Toxicities (DLTs), Severe Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: From signing of the informed consent form (ICF) through 30 days after the last dose of study drug (approximately 8 years)
- Part 2 and Long-Term Extension: Number of Participants with Adverse Events (AEs), Severe AEs and SAEsTime frame: From signing of the ICF through 30 days after the last dose of study drug, (approximately 8 years)
Locations
46 sites in 7 countries. Site status is shown where the registry gives one.
Concord Hospital
Concord, New South Wales, Australia · Recruiting
The Tweed Hospital
Tweed Heads, New South Wales, Australia · Recruiting
Flinders Medical Centre
Woodville South, South Australia, Australia · Recruiting
St. Vincents Hospital Melbourne
Fitzroy, Victoria, Australia · Recruiting
Royal Melbourne Hospital
Melbourne, Victoria, Australia · Recruiting
Ballarat Oncology & Haematology Service
Wendouree, Victoria, Australia · Recruiting
Hospital de Clinicas de Porto Alegre
Porto Alegre, Brazil · Recruiting
IMV-Pesquisa Cardiologica Sociedade Simples
Porto Alegre, Brazil · Recruiting
Albert Einstein Sociedade Beneficente Israelita Brasiliera
São Paulo, Brazil · Recruiting
Hospital Beneficencia Portuguesa de Sao Paulo
São Paulo, Brazil · Recruiting
Hospital Das Clinicas Da Faculdade de Medicina Da U S P
São Paulo, Brazil · Recruiting
Instituto de Ensino e Pesquisas Sao Lucas
São Paulo, Brazil · Recruiting
CHU Amiens - Hopital Sud
Amiens, France · Completed
Hopital Morvan
Brest, France · Completed
Hopital Prive Sevigne
Cesson-Sévigné, France · Completed
Centre Hospitalier Lyon Sud
Lyon, France · Recruiting
Institut de Cancerologie du Gard
Nîmes, France · Recruiting
Hopital de la Source - CHR Orleans
Orléans, France · Completed
Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari
Bari, Italy · Recruiting
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi
Bologna, Italy · Recruiting
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Brescia, Italy · Recruiting
Azienda Ospedaliera Universitaria Careggi
Florence, Italy · Recruiting
Ospedale Policlinico San Martino
Genova, Italy · Recruiting
ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center
Milan, Italy · Recruiting
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
Milan, Italy · Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Milan, Italy · Completed
Arcispedale S. Maria Nuova Azienda Ospedaliera di Reggio Emilia
Reggio Emilia, Italy · Recruiting
Azienda Ospedaliera Universitaria Policlinico Umberto I
Roma, Italy · Recruiting
Azienda Socio Sanitaria Territoriale Sette Laghi
Varese, Italy · Recruiting
Azienda Ospedaliera Universitaria Integrata Verona
Verona, Italy · Recruiting
Gachon University Gil Medical Center
Incheon, South Korea · Completed
Samsung Medical Center
Seoul, South Korea · Completed
Seoul St. Marys Hospital, The Catholic University of Korea
Seoul, South Korea · Recruiting
Soonchunhyang University Seoul Hospital
Seoul, South Korea · Recruiting
ICO Badalona - Hospital Universitari Germans Trias i Pujol
Badalona, Spain · Recruiting
Hospital Universitari Vall d'Hebron
Barcelona, Spain · Recruiting
Hospital Universitario La Paz
Madrid, Spain · Recruiting
Hospital Universitario La Princesa
Madrid, Spain · Recruiting
Hospital Universitario de Salamanca
Salamanca, Spain · Recruiting
Hospital Clinico Universitario de Valencia
Valencia, Spain · Recruiting
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.